Our study uncovers a potential causal relationship between apoA-I levels and the risk of gestational diabetes, which could facilitate early prediction of GDM, inform prevention strategies and treatment interventions, and promote the advancement of personalized medicine. Here, APOA1 is linked to gestational diabetes.